- Sputnik International
Asia
Find top stories and features from Asia and the Pacific region. Keep updated on major political stories and analyses from Asia and the Pacific. All you want to know about China, Japan, North and South Korea, India and Pakistan, Southeast Asia and Oceania.

A One-Day Flu Treatment? Japan Plans to Release New Anti-Influenza Medicine

© AFP 2023 / KAZUHIRO NOGI Japanese school girls wearing facemasks
Japanese school girls wearing facemasks - Sputnik International
Subscribe
The world's first drug that can cure a person from the flu in just one day will reportedly be released by a pharmaceutical company in Japan in 2018.

A nurse prepares an injection of the influenza vaccine at Massachusetts General Hospital - Sputnik International
World
Researchers Make Breakthrough in Creating Universal Flu Shot
The Japanese pharmaceutical company Shionogi & Co. has announced that it will release what it claims will be the world's first one-day treatment for influenza already in 2018, according to the Japanese newspaper Nikkei Shimbun.

Unlike existing analogues, the new medicine, which is taken orally, prevents the spread of the flu virus and ultimately kills it.

Medics explained that the new drug works by inhibiting the activity of enzymes that aid in the propagation of influenza viruses that enter the body through the throat or nose.

Nikkei Shimbun compared the new medicine favorably with the current influenza treatment Tamiflu, which the newspaper said fails to stop the spread of the virus and must be taken for about five days.

Health Workers Dispose of Chickens Because of Bird Flu Outbreak - Sputnik International
Budget Cuts to Hurt NY During Worst Bird Flu Epidemic in Decade – Senator
The drug has already passed its first clinical trials in Japan and has proven itself to be effective.

The second phase will begin in November, when the number of influenza cases typically increases dramatically. The drug will reportedly be tested on several hundred patients.

The Japanese Health Ministry has, meanwhile, put the new drug into a fast-track approval process for sales to commence as early as 2018.

Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала